While the active molecule is the same, the packaging and the regulatory path differ
Prefrontal cortex GABAergic deficits and circuit dysfunction in the pathophysiology and treatment of chronic stress and depression
The documented benefits span cognitive function improvement, sleep quality enhancement, mood regulation , brain injury recovery , and potential neurodegenerative disease support
At the same time, payers are quietly rebelling: benefit budgets are strained, employers are pulling coverage, and policymakers are questioning how to sustain access to drugs that may be lifelong therapies for millions
Final Thoughts GLP-1 therapy has transformed the management of obesity by targeting the biological mechanisms responsible for hunger, cravings, and weight gain